- Report
- March 2024
- 181 Pages
Global
From €3237EUR$3,374USD£2,799GBP
€3597EUR$3,749USD£3,111GBP
- Report
- March 2024
- 199 Pages
Global
From €3237EUR$3,374USD£2,799GBP
€3597EUR$3,749USD£3,111GBP
- Report
- February 2024
- 175 Pages
Global
From €4797EUR$5,000USD£4,148GBP
- Report
- January 2024
- 175 Pages
Global
From €4797EUR$5,000USD£4,148GBP
- Report
- December 2023
- 200 Pages
Global
From €4797EUR$5,000USD£4,148GBP
- Report
- November 2023
- 150 Pages
Global
From €4654EUR$4,850USD£4,024GBP
- Report
- May 2024
- 174 Pages
Global
From €5229EUR$5,450USD£4,522GBP
- Report
- May 2024
- 380 Pages
Global
From €5229EUR$5,450USD£4,522GBP
- Report
- March 2024
- 148 Pages
Global
From €3741EUR$3,899USD£3,235GBP
- Report
- October 2023
- 182 Pages
Global
From €4701EUR$4,900USD£4,065GBP
- Report
- February 2024
- 120 Pages
Global
From €4558EUR$4,750USD£3,941GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1919EUR$2,000USD£1,659GBP
- Clinical Trials
- February 2024
- 80 Pages
Global
From €1919EUR$2,000USD£1,659GBP
- Report
- February 2024
- 150 Pages
Global
From €4078EUR$4,250USD£3,526GBP
- Report
- August 2023
- 133 Pages
Global
From €7196EUR$7,500USD£6,223GBP
- Report
- July 2023
- 129 Pages
Global
From €7196EUR$7,500USD£6,223GBP
- Report
- April 2024
- 182 Pages
Global
From €4701EUR$4,900USD£4,065GBP
- Report
- January 2024
- 200 Pages
Global
From €3982EUR$4,150USD£3,443GBP
- Report
- December 2023
- 159 Pages
Global
From €2399EUR$2,500USD£2,074GBP
- Report
- April 2019
- 208 Pages
Global
From €2877EUR$2,999USD£2,488GBP
Selective Serotonin Reuptake Inhibitors (SSRIs) are a class of drugs used to treat mental disorders such as depression, anxiety, and obsessive-compulsive disorder. SSRIs work by increasing the amount of serotonin, a neurotransmitter, in the brain. This helps to improve mood and reduce symptoms of mental illness. SSRIs are generally considered to be safer and more effective than other types of antidepressants, and they are often prescribed as a first-line treatment for mental disorders.
The SSRI market is highly competitive, with many pharmaceutical companies offering different brands of SSRIs. Some of the major players in the market include Pfizer, GlaxoSmithKline, Eli Lilly, and AstraZeneca. These companies have developed a wide range of SSRIs, including Prozac, Zoloft, Paxil, and Lexapro. Other companies, such as Mylan and Teva, also offer generic versions of SSRIs. Show Less Read more